{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:19:30Z","timestamp":1789586370297,"version":"build-2803163510"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Neoepitopes have attracted much attention as targets for immunotherapy against cancer. Therefore, efficient neoepitope screening technology is an essential step in the development of personalized vaccines. Circular RNAs (circRNAs) are generated by back-splicing and have a single-stranded continuous circular structure. So far, various circRNAs have been poorly characterized, though new evidence suggests that a few translated circRNAs may play a role in cancer. In the present study, circRNA was used as a source of neoepitope, a novel strategy as circRNA-derived neoepitopes have never been previously explored. The present study reports CIRC_neo (circRNA-derived neoepitope prediction pipeline), which is a comprehensive and automated bioinformatic pipeline for the prediction of circRNA-derived neoepitopes from RNA sequencing data. The computational prediction from sequencing data requires complex computational workflows to identify circRNAs, derive the resulting peptides, infer the types of human leukocyte antigens (HLA I and HLA II) in patients, and predict the neoepitopes binding to these antigens. The present study proposes a novel source of neoepitopes. The study focused on cancer-specific circRNAs, which have greatly expanded the source pool for neoepitope discovery. The statistical analysis of different features of circRNA-derived neoepitopes revealed that circRNAs could produce long proteins or truncated proteins. Because the peptides were completely foreign to the human body, they could be highly immunogenic. Importantly, circRNA-derived neoepitopes capable of binding to HLA were discovered. In the current study, circRNAs were systematically analyzed, revealing potential targets and novel research clues for cancer diagnosis, treatment, and prospective personalized vaccine research.<\/jats:p>","DOI":"10.3389\/fonc.2023.1098523","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T04:39:50Z","timestamp":1681274390000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Circular RNAs as a potential source of neoepitopes in cancer"],"prefix":"10.3389","volume":"13","author":[{"given":"Jiaqi","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baorui","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12943-021-01335-5","article-title":"mRNA vaccine for cancer immunotherapy","volume":"20","author":"Miao","year":"2021","journal-title":"Mol Cancer."},{"key":"B2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev-immunol-042617-053402","article-title":"Cancer neoantigens","volume":"37","author":"Schumacher","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30516-8","article-title":"Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: A pan-cancer analysis","volume":"18","author":"Turajlic","year":"2017","journal-title":"Lancet Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"14184","DOI":"10.1038\/s41598-019-50738-4","article-title":"RNA Transcription and splicing errors as a source of cancer frameshift neoantigens for vaccines","volume":"9","author":"Shen","year":"2019","journal-title":"Sci Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4239","article-title":"Intron retention is a source of neoepitopes in cancer","volume":"36","author":"Smart","year":"2018","journal-title":"Nat Biotechnol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccell.2018.07.001","article-title":"Comprehensive analysis of alternative splicing across tumors from 8,705 patients","volume":"34","author":"Kahles","year":"2018","journal-title":"Cancer Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.02.014","article-title":"The RNA binding protein quaking regulates formation of circRNAs","volume":"160","author":"Conn","year":"2015","journal-title":"Cell."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-019-0158-7","article-title":"The biogenesis, biology and characterization of circular RNAs","volume":"20","author":"Kristensen","year":"2019","journal-title":"Nat Rev Genet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2015.82","article-title":"Circular RNA is enriched and stable in exosomes: A promising biomarker for cancer diagnosis","volume":"25","author":"Li","year":"2015","journal-title":"Cell Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.361","article-title":"Circular RNAs in cancer: opportunities and challenges in the field","volume":"37","author":"Kristensen","year":"2018","journal-title":"Oncogene."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab418","article-title":"Sensitive, reliable and robust circRNA detection from RNA-seq with CirComPara2","volume":"23","author":"Gaffo","year":"2022","journal-title":"Brief Bioinform"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2015.06.003","article-title":"Circular RNA: A new star of non-coding RNAs","volume":"365","author":"Qu","year":"2015","journal-title":"Cancer Lett"},{"key":"B15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jbiotec.2016.09.011","article-title":"Circular RNAs are miRNA sponges and can be used as a new class of biomarker","volume":"238","author":"Kulcheski","year":"2016","journal-title":"J Biotechnol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.molcel.2017.02.017","article-title":"Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis","volume":"66","author":"Legnini","year":"2017","journal-title":"Mol Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molcel.2017.02.021","article-title":"Translation of CircRNAs","volume":"66","author":"Pamudurti","year":"2017","journal-title":"Mol Cell"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2017.31","article-title":"Extensive translation of circular RNAs driven by N6-methyladenosine","volume":"27","author":"Yang","year":"2017","journal-title":"Cell Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2017.70","article-title":"Circular RNAs: Coding or non-coding","volume":"27","author":"Schneider","year":"2017","journal-title":"Cell Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12943-020-01179-5","article-title":"A novel protein encoded by circFNDC3B inhibits tumor progression and EMT through regulating snail in colon cancer","volume":"19","author":"Pan","year":"2020","journal-title":"Mol Cancer."},{"key":"B21","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.cell.2018.12.021","article-title":"The landscape of circular RNA in cancer","volume":"176","author":"Vo","year":"2019","journal-title":"Cell."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4475","DOI":"10.1038\/s41467-018-02847-3","article-title":"A peptide encoded by circular form of LINC-PINT suppresses oncogenic transcriptional elongation in glioblastoma","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa279","article-title":"Rolling-translated EGFR variants sustain EGFR signaling and promote glioblastoma tumorigenicity","volume":"23","author":"Liu","year":"2021","journal-title":"Neuro Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201643581","article-title":"CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells","volume":"18","author":"Li","year":"2017","journal-title":"EMBO Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0465-8","article-title":"Widespread intronic polyadenylation inactivates tumour suppressor genes in leukaemia","volume":"561","author":"Lee","year":"2018","journal-title":"Nature."},{"key":"B26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.10.062","article-title":"Genome-wide analysis of drosophila circular RNAs reveals their structural and sequence properties and age-dependent neural accumulation","volume":"9","author":"Westholm","year":"2014","journal-title":"Cell Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.09.001","article-title":"Complementary sequence-mediated exon circularization","volume":"159","author":"Zhang","year":"2014","journal-title":"Cell."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgg.2018.07.006","article-title":"IRESfinder: Identifying RNA internal ribosome entry site in eukaryotic cell using framed k-mer features","volume":"45","author":"Zhao","year":"2018","journal-title":"J Genet Genomics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1093\/nar\/gkt006","article-title":"CPAT: Coding-potential assessment tool using an alignment-free logistic regression model","volume":"41","author":"Wang","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx428","article-title":"CPC2: A fast and accurate coding potential calculator based on sequence intrinsic features","volume":"45","author":"Kang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu548","article-title":"OptiType: precision HLA typing from next-generation sequencing data","volume":"30","author":"Szolek","year":"2014","journal-title":"Bioinformatics."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/humu.23230","article-title":"HLA-HD: An accurate HLA typing algorithm for next-generation sequencing data","volume":"38","author":"Kawaguchi","year":"2017","journal-title":"Hum Mutat"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3344","article-title":"Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes","volume":"33","author":"Shukla","year":"2015","journal-title":"Nat Biotechnol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700893","article-title":"NetMHCpan-4.0: Improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data","volume":"199","author":"Jurtz","year":"2017","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0289-6","article-title":"Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes","volume":"37","author":"Racle","year":"2019","journal-title":"Nat Biotechnol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00251-005-0781-7","article-title":"The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage","volume":"57","author":"Nielsen","year":"2005","journal-title":"Immunogenetics"},{"key":"B38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: A global overview and recent trends","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur Urol."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0177-5","article-title":"Challenges to curing primary brain tumours","volume":"16","author":"Aldape","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2018.10.008","article-title":"circGprc5a promoted bladder oncogenesis and metastasis through Gprc5a-targeting peptide","volume":"13","author":"Gu","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-021-00639-4","article-title":"Circular RNA-encoded oncogenic e-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR-STAT3 signalling","volume":"23","author":"Gao","year":"2021","journal-title":"Nat Cell Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-017-0019-9","article-title":"A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis","volume":"37","author":"Zhang","year":"2018","journal-title":"Oncogene."},{"key":"B43","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-019-1056-5","article-title":"A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by competing with active phosphoinositide-dependent kinase-1","volume":"18","author":"Xia","year":"2019","journal-title":"Mol Cancer."},{"key":"B44","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.omtn.2019.07.023","article-title":"circFBXW7 inhibits malignant progression by sponging miR-197-3p and encoding a 185-aa protein in triple-negative breast cancer","volume":"18","author":"Ye","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx166","article-title":"Novel role of FBXW7 circular RNA in repressing glioma tumorigenesis","volume":"110","author":"Yang","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nature14426","article-title":"Mutant MHC class II epitopes drive therapeutic immune responses to cancer","volume":"520","author":"Kreiter","year":"2015","journal-title":"Nature."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1101\/gad.314856.118","article-title":"A length-dependent evolutionarily conserved pathway controls nuclear export of circular RNAs","volume":"32","author":"Huang","year":"2018","journal-title":"Genes Dev"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2022.2154846","article-title":"Development of a novel circular mRNA vaccine of six protein combinations against staphylococcus aureus","volume":"19","author":"Zhu","year":"2022","journal-title":"J Biomol Struct Dyn."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0434-2","article-title":"Immunogenic neoantigens derived from gene fusions stimulate T cell responses","volume":"25","author":"Yang","year":"2019","journal-title":"Nat Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1098523\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T04:39:55Z","timestamp":1681274395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1098523\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":49,"alternative-id":["10.3389\/fonc.2023.1098523"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1098523","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"article-number":"1098523"}}